ThursdayOct 21, 2010 8:53 am

PacificHealth Laboratories, Inc. (PHLI.OB) Overhauls Business Model, Focuses on Key Segments for Big Profits in 2011

PacificHealth Labs, www.pacifichealthlabs.com – the pioneering nutrition technologist behind some of the most effective, patented, protein-based, peptide-stimulating sports performance and weight loss nutritionals available in the marketplace, announced sweeping changes yesterday. President and CEO of PHLI, Fred Duffner, acknowledged that the shift away from the Company’s core and heritage in sports nutrition over the last three years did not yield the kind of strength and overall shareholder value desired. As a result, while PHLI will continue to develop the weight management segment, primary focus will again be directed towards the exceptional endurance athlete-focused products. To this end, Duffner announced a…

Continue Reading

ThursdayOct 21, 2010 8:51 am

Vivakor, Inc. (VIVK.OB) and MIT Holding Inc. Team Up to Distribute Revolutionary Biological Transport/Storage Vials

Vivakor, www.vivakor.com – the biotech/biomed company with research proficiency that allows strategic acquisition/development of parallel technologies in molecular medicine, electro-optics, biological handling and others fields, reported yesterday entry into an exclusive licensing agreement calling for all worldwide distribution of the Company’s Vivathermic Vials to be managed by MIT Holding Inc. (MITD.OB). The revolutionary Vivathermic Vial has unsurpassed sensitivity as a biological transport/storage system, far exceeding the performance of anything else available, and is ideal for all types of biological preservation, even the most sensitive stem cells. Through its three wholly-owned subsidiaries, MITD is a well-positioned wholesale distributor of pharmaceuticals but…

Continue Reading

ThursdayOct 21, 2010 8:01 am

Aradigm Corp. (ARDM.OB) Releases Positive Phase 2b Data for Lung Disease Treatment

Specialty pharmaceutical company Aradigm Corp. is focused on the development of its portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases. Its portfolio includes product candidates to treat bronchiectasis, cystic fibrosis, inhalation anthrax and tularemia infections and smoking cessation. The company today announced that statistical significance was achieved in the company’s recently concluded six-month phase 2b study (ORBIT-2) with Aradigm's once-daily dual release ciprofloxacin for inhalation (DRCFI, ARD-3150) in patients with non-cystic fibrosis bronchiectasis, a lung disease in which airways enlarge. Associate Professor David Serisier of the Mater Adult Hospital, Brisbane, Australia, a pulmonary physician and…

Continue Reading

ThursdayOct 21, 2010 7:52 am

Third Party Studies Aim to Validate Golden Spirit Enterprises Ltd.’s (GSPT.OB) Terralene Fuel

Yesterday, environmentally conscious green technology company, Golden Spirit Enterprises Ltd., reported that it must provide certain information to interested parties in order to verify the effectiveness and practicality of Terralene Fuel, its patented alternative fuel formulation. The information pertains to the company’s objective in developing a fuel specification standard that will incorporate Terralene. The information includes studies from various independent third parties. First, the Canadian Defense Department conducted an analysis of Terralene, characterizing its physical and chemical properties; the fuels were then used in a combustion engine. The study showed that Terralene emissions produced fewer hydrocarbons, NOx, carbon monoxide and…

Continue Reading

ThursdayOct 21, 2010 7:49 am

TNFG Corp. (TNFG.OB) Completes Asset Sale

Yesterday, TNFG Corp. and Lightspeed Financial, Inc. announced that they completed the transaction whereby Lightspeed has acquired 100 percent of the membership interest of Terra Nova Financial, LLC for a purchase price of approximately $27.6 million. The purchase price consists of an initial cash payment of $22.6 million and a $5.0 million promissory note bearing interest at a rate of 8% and due within six months of closing or the earlier release of clearing deposits held Terra Nova's clearing firm. TNFG Corporation estimates that they will have approximately $24 million to $27 million in cash available for distribution to their…

Continue Reading

ThursdayOct 21, 2010 7:46 am

Medizone International, Inc. (MZEI.OB) Announces Successful Completion of Testing of AsepticSure

Yesterday, Medizone International Inc., a research and development company, announced the successful completion of the first round of beta testing for its AsepticSure system at Hotel Dieu Hospital in Ontario, Canada, which is affiliated with Queen's University. The system will be used to decontaminate and sterilize surgical suites, emergency rooms, intensive care units, patient rooms and schools, among other areas prone to contamination. A variant is being developed for the government to be used in bio-terrorism countermeasures. Additional variants will be developed for commercial use; for example, sports facilities and food processing plants. Dr. Michael E. Shannon stated, "We are…

Continue Reading

WednesdayOct 20, 2010 3:52 pm

Acorn Energy (ACFN) Reports Preliminary Third Quarter Sales

Acorn Energy reported a large increase in sales in the third quarter of 2010 compared to last year as the company benefited from increased orders in many of its business segments. Acorn Energy said that preliminary unaudited sales for the third quarter of 2010 would be $10.5 million, up 63% relative to the third quarter of 2009. The company will report full financial results early in November 2010. Although the company saw good growth in sales on a year over year basis, Acorn Energy reduced guidance for sales for the full year 2010. The company had originally forecasted sales to…

Continue Reading

WednesdayOct 20, 2010 3:51 pm

ITEX Corp. (ITEX.OB) Posts Solid Q4 Results and Key Highlights

ITEX Corp., the Membership Trading Community(SM), serves as a marketplace for cashless business transactions in North America. The company today announced its financial results for the fourth quarter and fiscal year ended July 31, 2010, posting solid results generated from acquisitions and successful management guidance. The company reported income from operations up 63 percent to $1.674 million from $1.027 million last year. Net income increased 56 percent to $946,000 from $607,000 reported for the fourth quarter of last year. Earnings per share increased 53 percent to $0.26 from $0.17 last year. Revenue grew 3 percent to $16.925 million compared to…

Continue Reading

WednesdayOct 20, 2010 1:12 pm

Finding a Cure for Breast Cancer

As you probably already know by now, October is National Breast Cancer Awareness Month. A leading type of cancer among women, only second to lung cancer, much research is being done to discover a cure. It has been estimated that 25 deaths due to breast cancer occur each year for every 100,000 women in the United States. As a result of continued progress with cancer research, the breast cancer death rate has steadily decreased but no "magic bullet" currently exists. This year we’re supporting the cause through a donation to the National Breast Cancer Foundation (www.nationalbreastcancer.org). This organization not only…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered